The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells-Reference-Cited by-同舟云学术

The immunotherapeutic effects of recombinant Bacillus Calmette-Guérin resistant to antimicrobial peptides on bladder cancer cells

Published:2019-01 Issue:1 Volume:509 Page:167-174
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Cho Min-Ji,Kim Myeong Joo,Kim Kijeong,Choi Young Wook,Lee Sang-Jin,Whang Young Mi,Chang In Ho^ORCID

Funder

Chung-Ang University

Korea Health Technology R&D Project

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference17 articles.

1. BCG and the treatment of superficial bladder cancer;Moss;DICP,1991

2. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder;Lamm;J. Urol.,1995

3. Antimicrobial peptides: premises and promises;Reddy;Int. J. Antimicrob. Agents,2004

4. Cathelicidins, essential gene-encoded mammalian antibiotics;Zaiou;J. Mol. Med. (Berl.),2002

5. A functional dlt operon, encoding proteins required for incorporation of d-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae;Kovacs;J. Bacteriol.,2006

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-Bacillus Calmette-Guérin immunotherapies for improved bladder cancer treatment;Journal of Zhejiang University-SCIENCE B;2024-07

2. Advances in drug delivery systems, challenges and future directions;Heliyon;2023-06

3. Evaluating the Effectiveness of Intravesical Instillation of BCG by Modified Maintenance Method in Patients With High-Risk Ta and T1 Bladder Cancer: A Randomized Clinical Trial;Clinical Medicine Insights: Oncology;2023-01

4. Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model;Investigative and Clinical Urology;2023

5. Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels;Biomedicines;2022-07-21